Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	11.84	31.79	28.43
Graham Fair Price	-16.65	971.88	1165.95
PEG	265.47	-0.73	0.20
Price/Book	8.62	2.16	1.98
Price/Cash Flow	inf	0.00	79.70
Prices/Earnings	63.79	23.61	14.41
Price/Sales	16.29	3.88	3.33
Price/FCF	inf	0.00	79.70
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-4.70	0.39	0.41
Operating Margin	-19.26	0.07	0.09
ROA	-34.21	0.02	0.03
ROE	0.03	0.02	-33.68
ROIC	0.03	0.03	-22.51
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.39	< 0.005	12388.97
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.67	-0.23	-66.12
EPS QOQ	0.72	-0.32	-55.18
FCF QOQ	0.04	-1.00	2186.54
Revenue QOQ	0.11	-0.04	-61.37
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	55.77	58.68	5.23
Days Sales Outstanding (DSO)	17.96	8.59	-52.17
Inventory Turnover	1.61	1.53	-4.97
Debt/Capitalization	0.00	0.02	100.00
Quick Ratio	2.99	2.74	-8.33
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	1324.97	1356.17	2.36
Cash	729.16	773.41	6.07
Capex	0.00	0.00	0.00
Free Cash Flow	32.99	0.00	inf
Revenue	788.69	754.03	-4.39
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	3.97	3.96	-0.26
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-9.77	-10.46	-7.10
Naive Interpretation	Member

06 - Financial Health · Bad

Rating